• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

15-Second Heart Failure Test: Eko’s AI Stethoscope Gets FDA Nod

by Fred Pennic 04/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
15-Second Heart Failure Test: Eko's AI Stethoscope Gets FDA Nod

What You Should Know:

– Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.

– Built in collaboration with Mayo Clinic, the AI allows U.S. healthcare providers to detect Low Ejection Fraction (LVEF), a crucial indicator of heart failure, in just 15 seconds using a standard Eko stethoscope during a routine physical exam.

Importance of Early Detection

The advancement in early detection signifies a major medical innovation for cardiovascular disease.  In the US alone, over 6 million individuals struggle with heart failure, with half experiencing HFrEF, a condition where the heart cannot pump blood efficiently. Traditionally, diagnosing heart failure often relies on echocardiography, a tool unavailable in many primary care settings due to its cost, specialized training requirements, and time constraints.  Consequently, many heart failure cases go undiagnosed until patients experience severe symptoms, leading to poorer outcomes and higher healthcare costs.

Eko’s AI Solution Integrates Seamlessly into Existing Workflows

Eko’s Low EF AI disrupts this paradigm by enabling rapid and accessible LVEF detection during routine stethoscope exams. This integration into existing workflows allows for earlier intervention and potentially life-saving treatment.  The Low EF AI seamlessly integrates with Eko’s existing SENSORA Cardiac Early Detection Platform, which already boasts FDA-cleared algorithms for detecting atrial fibrillation (AFib) and structural heart murmurs. When the AI detects Low EF during a primary care exam,  patients can be promptly referred to cardiology for definitive diagnosis and treatment planning.

Rigorous Clinical Validation Underscores Accuracy

Eko’s Low EF AI was meticulously developed and validated.  Here are some key highlights:

Robust Training: Trained on a vast dataset exceeding 100,000 paired ECGs and echocardiograms from unique patients.

Multi-Site Clinical Study: Clinically validated in a comprehensive study involving over 3,456 patients, demonstrating a strong ability to differentiate between normal and low EF.

Independent Validation: An independent study by Imperial College London, published in Lancet Digital Health, further confirmed the AI’s accuracy with an impressive AUROC of 0.85 for detecting LVEF below 40%.

Real-World Effectiveness: The success of Eko’s deployment in over 100 clinics across London and Wales following the Imperial College London study underscores its effectiveness in real-world settings.

Pregnant Women’s Health: A Mayo Clinic-led study involving nearly 1,200 pregnant women in Nigeria showcased the AI’s ability to identify twice the number of cardiomyopathy cases compared to standard care, highlighting its potential to improve maternal health outcomes.

“The stethoscope, the most recognizable symbol of healthcare, touches the lives of an estimated one billion people around the globe every year”, said Connor Landgraf, co-founder & CEO of Eko Health. “With Eko’s Low EF AI, we’ve transformed the icon of medicine into an AI-powered heart failure early detection tool that can help improve access to care for millions of patients, at a fraction of the time and cost of echocardiography. It’s been a privilege to work alongside Mayo Clinic in this groundbreaking endeavor.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Eko Devices

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |